Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) EBIT (2016)

Microbot Medical's EBIT history spans 7 years, with the latest figure at -$1.9 million for Q3 2016.

  • For the quarter ending Q3 2016, EBIT rose 81.18% year-over-year to -$1.9 million, compared with a TTM value of -$29.1 million through Sep 2016, up 23.38%, and an annual FY2020 reading of -$9.1 million, down 25.54% over the prior year.
  • EBIT for Q3 2016 was -$1.9 million at Microbot Medical, up from -$8.9 million in the prior quarter.
  • The five-year high for EBIT was -$1.9 million in Q3 2016, with the low at -$10.0 million in Q3 2015.
  • Average EBIT over 5 years is -$7.3 million, with a median of -$6.8 million recorded in 2014.
  • Year-over-year, EBIT tumbled 56.56% in 2015 and then skyrocketed 81.18% in 2016.
  • Tracing MBOT's EBIT over 5 years: stood at -$6.2 million in 2012, then tumbled by 45.53% to -$9.0 million in 2013, then decreased by 8.61% to -$9.7 million in 2014, then increased by 12.64% to -$8.5 million in 2015, then surged by 77.88% to -$1.9 million in 2016.
  • Per Business Quant, the three most recent readings for MBOT's EBIT are -$1.9 million (Q3 2016), -$8.9 million (Q2 2016), and -$9.8 million (Q1 2016).